Silicon Valley-based Graybug Vision Inc, a clinical stage pharmaceutical company, has secured $80 million in Series C financing. CBC Group led the round with participation from other investors that included Deerfield Management, OrbiMed Advisors and Hatteras Venture Partners.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.